Study of SGN-40 in Patients With Refractory or Recurrent Multiple Myeloma

This study has been completed.
Sponsor:
Collaborator:
Genentech, Inc.
Information provided by:
Seattle Genetics, Inc.
ClinicalTrials.gov Identifier:
NCT00079716
First received: March 11, 2004
Last updated: December 17, 2014
Last verified: December 2014